REHOVOT, Israel, May 29, 2019 /PRNewswire/ -- Techsomed, developer of BioTrace™, the world's first image analysis system for predicting post-treatment ablation morphology in real time, has secured ...
MINNEAPOLIS and TEL AVIV, Israel, Oct. 16, 2025 /PRNewswire/ -- Techsomed Ltd., a pioneering medical AI-powered software company specializing in image-guided therapy is pleased to announce a ...
TEL AVIV, Israel, Sept. 22, 2025 /PRNewswire/ -- Techsomed, a leader in AI-Driven Precision for Image-Guided Care, today announces U.S. FDA 510 (k) clearance expanding indications for BioTraceIO360* ...
New Senior Executive to Accelerate U.S. Launch of AI-Powered BioTraceIO™ Software Suite for Image-Guided Ablation Therapy REHOVOT, Israel, Sept. 24, 2024 /PRNewswire/ -- Techsomed Ltd., a pioneering ...
REHOVOT, Israel , Jan. 8, 2024 /PRNewswire/ -- Techsomed Medical Technologies LTD is thrilled to announce that FDA has granted De Novo clearance for its BioTraceIO, a groundbreaking ultrasound-based ...
REHOVOT, Israel, June 26, 2023 /PRNewswire/ -- Techsomed Ltd., the developer of BioTrace, an AI powered software platform for real time ablation zone imaging and treatment precision enhancement, ...